Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 50180M108 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Deep Track Capital, LP
13D/A
|
11.7% |
2/10/2026
Event 2/6/2025
|
||
| Deep Track Biotechnology Master Fund, Ltd. | 9.4% | |||
| Deep Track Special Opportunities Fund, LP | 2.3% | |||
| Deep Track Capital, LP | 11.7% | |||
| David Kroin | 11.7% | |||
|
RA Capital Management, L.P.
13G/A
|
8.7% |
2/17/2026
Event 12/31/2025
|
||
| RA Capital Management, L.P. | 8.7% | |||
| Peter Kolchinsky | 8.7% | |||
| Rajeev Shah | 8.7% | |||
| RA Capital Healthcare Fund, L.P. | 8.7% | |||
|
Commodore Capital LP
13G/A
|
6.8% |
5/15/2026
Event 3/31/2026
|
||
| Commodore Capital LP | 6.8% | |||
| Commodore Capital Master LP | 6.8% | |||
| Robert Egen Atkinson | 6.8% | |||
| Michael Kramarz | 6.8% | |||
| BlackRock, Inc. 13G/A | 6.3% |
7/29/2026
Event 6/30/2026
|
||
|
Pontifax Management 4 G.P. (2015) Ltd.
13D
|
6.3% |
9/25/2025
Event 9/12/2025
|
||
| Pontifax Management 4 G.P. (2015) Ltd. | 6.3% | |||
| Pontifax VI G.P. L.P. | 6.3% | |||
| Ran Nussbaum | 6.3% | |||
| Tomer Kariv | 6.3% | |||
| JPMorgan Chase & Co 13G | 5.2% |
7/16/2026
Event 6/30/2026
|
||
|
TCG Crossover GP II, LLC
13G/A
|
5.0% |
8/14/2026
Event 6/30/2026
|
||
| TCG Crossover GP II, LLC | 5.0% | |||
| TCG Crossover Fund II, L.P. | 5.0% | |||
| Chen Yu | 5.0% | |||
|
Caligan Partners LP
13G
|
5.0% |
5/15/2026
Event 3/31/2026
|
||
| Caligan Partners LP | 5.0% | |||
| Johnson David Edward | 5.0% | |||
|
Trails Edge Capital Partners, LP
13G
|
5.0% |
12/31/2025
Event 12/24/2025
|
||
| Trails Edge Capital Partners, LP | 5.0% | |||
| Trails Edge Biotechnology Master Fund, LP | 5.0% | |||
| Ortav Yehudai | 5.0% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (1) | ||||
| BlackRock Portfolio Management LLC 13G/A | 3.8% |
1/21/2026
Event 12/31/2025
|
||